Back
Heron Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
HRTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15
HRTX
Heron Therapeutics
Last Price:
1.07
Seasonality Move:
17.79%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Heron Therapeutics Price Quote
$1.07
Heron Therapeutics Key Stats
Sell
15
Heron Therapeutics (HRTX)
is a Sell
Day range:
$1.06 - $1.10
52-week range:
$1.04 - $3.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.18
P/B ratio:
0%
Volume:
1.3M
Avg. volume:
1.8M
1-year change:
-21.9%
Market cap:
$162.7M
Revenue:
$127M
EPS:
$-0.16
How Much Does Heron Therapeutics Make?
-
How Much Are Heron Therapeutics's Sales Annually?
HRTX Revenues are $127M -
How Much Profit Does Heron Therapeutics's Make A Year?
HRTX net income is -$110.6M
Is Heron Therapeutics Growing As A Company?
-
What Is Heron Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.04% -
What Is Heron Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Heron Therapeutics Stock Price Performance
-
Did Heron Therapeutics Stock Go Up Last Month?
Heron Therapeutics share price went down by -39.89% last month -
Did HRTX's Share Price Rise Over The Last Year?
HRTX share price fell by -21.9% over the past 1 year
What Is Heron Therapeutics 52-Week High & Low?
-
What Is Heron Therapeutics’s 52-Week High Share Price?
Heron Therapeutics has traded as high as $3.93 over the past 52 weeks -
What Is Heron Therapeutics’s 52-Week Low Share Price?
Heron Therapeutics has traded as low as $1.04 over the past 52 weeks
Heron Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Heron Therapeutics?
-
How Much Debt Does Heron Therapeutics Have?
Total long term debt quarterly is $174.5M -
How Much Cash Does Heron Therapeutics Have?
Cash and short term investments quarterly total is $70.9M -
What Is Heron Therapeutics’s Book Value Per Share?
Book value per share is -0.26
Is Heron Therapeutics Cash Flow Positive?
-
What Is HRTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.3M -
What Is Heron Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $716K -
What Is Heron Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.5M
Heron Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
HRTX return on invested capital is -20.08% -
What Is Heron Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -12.62% -
What Is HRTX Return On Equity?
ROE is a measure of profitability and is 0%
Heron Therapeutics Earnings Date & Stock Price
-
What Is Heron Therapeutics's Stock Price Today?
A single share of HRTX can be purchased today for 1.07 -
What Is Heron Therapeutics’s Stock Symbol?
Heron Therapeutics trades on the nasdaq under the ticker symbol: HRTX -
When Is Heron Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Heron Therapeutics is scheduled on March 12, 2025 -
When Is HRTX's next ex-dividend date?
Heron Therapeutics's next ex-dividend date is May 12, 2020 -
How To Buy Heron Therapeutics Stock?
You can buy Heron Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Heron Therapeutics Competitors
-
Who Are Heron Therapeutics's Competitors?
Below is a list of companies who compete with Heron Therapeutics or are related in some way:
Heron Therapeutics Dividend Yield
-
What Is HRTX Dividend Yield?
Heron Therapeutics’s dividend yield currently is 0% -
What Is Heron Therapeutics’s Payout Ratio?
Heron Therapeutics’s payout ratio is 0% -
When Did Heron Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Heron Therapeutics’s Dividend Per Share?
Heron Therapeutics pays a dividend of $0.00 per share
Heron Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 14.29% |
Revenue: | 4.38% | -11.16% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 6.00 |
Upside from Last Price: | 460.75% |